{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T07:44:22Z","timestamp":1777621462296,"version":"3.51.4"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","award":["Investigator Sponsored Study"],"award-info":[{"award-number":["Investigator Sponsored Study"]}],"id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13063-017-2277-9","type":"journal-article","created":{"date-parts":[[2017,11,9]],"date-time":"2017-11-09T08:24:51Z","timestamp":1510215891000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Platelet inhibition during ticagrelor monotherapy versus ticagrelor plus aspirin in patients with coronary artery disease (TEMPLATE study): study protocol for a randomised controlled trial"],"prefix":"10.1186","volume":"18","author":[{"given":"Sarah","family":"Baos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy","family":"Underwood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucy","family":"Culliford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barnaby C.","family":"Reeves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris A.","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth","family":"Bowles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Baumbach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5523-511X","authenticated-orcid":false,"given":"Andrew","family":"Mumford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,11,9]]},"reference":[{"issue":"7329","key":"2277_CR1","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","volume":"324","author":"Antithrombotic Trialists Collaboration","year":"2002","unstructured":"Antithrombotic Trialists Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ. 2002;324(7329):71\u201386.","journal-title":"BMJ."},{"issue":"9281","key":"2277_CR2","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0140-6736(01)05701-4","volume":"358","author":"SR Mehta","year":"2001","unstructured":"Mehta SR, et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet. 2001;358(9281):527\u201333.","journal-title":"Lancet"},{"issue":"18","key":"2277_CR3","doi-asserted-by":"crossref","first-page":"e426","DOI":"10.1161\/CIR.0b013e318212bb8b","volume":"123","author":"JL Anderson","year":"2011","unstructured":"Anderson JL, et al. 2011 ACCF\/AHA focused update incorporated into the ACC\/AHA 2007 guidelines for the management of patients with unstable angina\/non-ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. Circulation. 2011;123(18):e426\u2013579.","journal-title":"Circulation"},{"issue":"10","key":"2277_CR4","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1111\/j.1538-7836.2011.04450.x","volume":"9","author":"PDM Leadbeater","year":"2011","unstructured":"Leadbeater PDM, et al. Aspirin has little additional anti-platelet effect in healthy volunteers receiving prasugrel. J Thromb Haemost. 2011;9(10):2050\u20136.","journal-title":"J Thromb Haemost"},{"issue":"14","key":"2277_CR5","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.110.967158","volume":"122","author":"D Sibbing","year":"2010","unstructured":"Sibbing D, et al. Response to letter regarding article, \u201cCytochrome 2C19*17 allelic variant, platelet aggregation, bleeding events, and stent thrombosis in clopidogrel-treated patients with coronary stent placement\u201d. Circulation. 2010;122(14), e479.","journal-title":"Circulation"},{"issue":"11","key":"2277_CR6","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","volume":"361","author":"L Wallentin","year":"2009","unstructured":"Wallentin L, et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. New Engl J Med. 2009;361(11):1045\u201357.","journal-title":"New Engl J Med"},{"issue":"3","key":"2277_CR7","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/j.1538-7836.2009.03714.x","volume":"8","author":"PCJ Armstrong","year":"2010","unstructured":"Armstrong PCJ, et al. Reduction of platelet thromboxane A(2) production ex vivo and in vivo by clopidogrel therapy. J Thromb Haemost. 2010;8(3):613\u20135.","journal-title":"J Thromb Haemost"},{"issue":"21","key":"2277_CR8","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1136\/hrt.2010.205724","volume":"96","author":"TD Warner","year":"2010","unstructured":"Warner TD, et al. Dual antiplatelet therapy in cardiovascular disease: does aspirin increase clinical risk in the presence of potent P2Y(12) receptor antagonists? Heart. 2010;96(21):1693\u20134.","journal-title":"Heart"},{"issue":"3","key":"2277_CR9","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1172\/JCI110814","volume":"71","author":"GA FitzGerald","year":"1983","unstructured":"FitzGerald GA, et al. Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man. J Clin Invest. 1983;71(3):676\u201388.","journal-title":"J Clin Invest"},{"issue":"10","key":"2277_CR10","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.4244\/EIJY15M11_07","volume":"12","author":"P Vranckx","year":"2016","unstructured":"Vranckx P, et al. Long-term ticagrelor monotherapy versus standard dual antiplatelet therapy followed by aspirin monotherapy in patients undergoing biolimus-eluting stent implantation: rationale and design of the GLOBAL LEADERS trial. EuroIntervention. 2016;12(10):1239\u201345.","journal-title":"EuroIntervention"},{"issue":"23","key":"2277_CR11","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","volume":"123","author":"R Mehran","year":"2011","unstructured":"Mehran R, et al. Standardized bleeding definitions for cardiovascular clinical trials a consensus report from the bleeding academic research consortium. Circulation. 2011;123(23):2736\u201347.","journal-title":"Circulation"},{"issue":"1","key":"2277_CR12","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/ccd.25520","volume":"85","author":"A Pandit","year":"2015","unstructured":"Pandit A, et al. Shorter (<\/=6\u00a0months) versus longer (>\/=12\u00a0months) duration dual antiplatelet therapy after drug eluting stents: a meta-analysis of randomized clinical trials. Catheter Cardiovasc Interv. 2015;85(1):34\u201340.","journal-title":"Catheter Cardiovasc Interv"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-017-2277-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,11,9]],"date-time":"2017-11-09T08:25:00Z","timestamp":1510215900000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-017-2277-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,9]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["2277"],"URL":"https:\/\/doi.org\/10.1186\/s13063-017-2277-9","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,9]]},"article-number":"529"}}